Clinical trials sponsored by Ruijin Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Ruijin Hospital

• 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
  NCT06608160 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
  NCT07080021 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
  NCT06567353 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
  NCT06541340 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
  NCT07649928 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Pancreatic Therapy Guided by MRD
  NCT06966440 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
  NCT05556603 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 3 locations
• BCI With 40Hz Stimulation in Alzheimer's Disease
  NCT07618481 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 2 locations
• Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients
  NCT06404697 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• CArdioMetabolism and Atherosclerotic PlaqUe progreSsion
  NCT05117424 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Cardiometabolic evalUation REgistry of Heart Failure
  NCT06939985 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
  NCT06829134 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
  NCT06496373 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
  NCT07306286 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
  NCT05870969 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Directional PSA Versus STN DBS for TD-PD
  NCT07700862 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%
  NCT07115992 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Efficacy and Safety of tACS for Depression: a Multicenter RCT Study
  NCT06891326 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
  NCT04517266 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
  NCT07131514 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
  NCT07504471 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
  NCT03829553 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
  NCT07306273 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
  NCT07085169 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations
• Metabolic Abnormalities, Lifestyle and Diet Pattern in Heart Failure
  NCT03951311 · Phase: Not specified · Ages: 14 Years to 90 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
  NCT06368141 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
  NCT04527861 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 11 locations
• Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
  NCT05916261 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
  NCT05552846 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
  NCT04973293 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
  NCT06796725 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 50 Years · Sex: All (male and female) · 1 location
• Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
  NCT06114225 · Phase: Phase 2 · Ages: 10 Years to 65 Years · Sex: All (male and female) · 1 location
• REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
  NCT06946953 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
  NCT05976412 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Risk Evaluation and Management in Heart Failure
  NCT02998788 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation
  NCT07498855 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Ruijin Neurobank of Alzheimer's Disease and Dementia
  NCT05623124 · Phase: Not specified · Ages: 50 Years to 90 Years · Sex: All (male and female) · 1 location
• SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
  NCT07198165 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
  NCT05576480 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SEEG-Guided DBS for Schizophrenia
  NCT07671261 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease
  NCT07774312 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
  NCT07232433 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety and Efficacy of IMPT or IMRT for Breast Cancer
  NCT06826885 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
  NCT05557552 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Shanghai At Risk for Alzheimer's Disease: a Cohort Study
  NCT05597410 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
  NCT07353463 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease
  NCT05887674 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 90 Years · Sex: All (male and female) · 1 location
• Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
  NCT06577532 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
  NCT06534658 · Phase: Not specified · Ages: 50 Years to 85 Years · Sex: All (male and female) · 8 locations
• Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
  NCT07035002 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
  NCT06534489 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
  NCT07157345 · Phase: Phase 1 · Ages: 40 Years to 65 Years · Sex: All (male and female) · 1 location
• The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
  NCT07015580 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
  NCT06601010 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Ruijin Hospital recruiting for?

Ruijin Hospital is the lead sponsor of 54 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.